Absci (ABSI) Profit After Tax (2020 - 2026)
Absci's (ABSI) quarterly Profit After Tax came in at -$29.6 million in Q1 2026, down 12.35% year-on-year from -$33.8 million in Q1 2025, and little changed quarter-over-quarter from -$29.6 million in Q4 2025.
Absci (ABSI) Profit After Tax (2020 - 2026) Analysis & Trends
Absci has disclosed Profit After Tax across 7 years of filings, most recently posting -$29.6 million for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$29.6 million, down 12.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$118.4 million (down 10.2% YoY), and the FY2025 annual result was -$115.2 million, down 11.71% from the prior year.
- Profit After Tax came in at -$29.6 million for Q1 2026 at Absci, roughly flat from -$29.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$19.5 million in Q4 2022 to a low of -$41.7 million in Q2 2023.
- The 5-year median for Profit After Tax is -$27.4 million (2024), against an average of -$27.3 million.
- Across the five-year window, Profit After Tax tumbled 169.06% in 2022 and surged 40.61% in 2024, its largest moves.
- Absci's Profit After Tax stood at -$19.5 million in 2022, then declined by 20.92% to -$23.5 million in 2023, then fell by 23.1% to -$29.0 million in 2024, then fell by 2.0% to -$29.6 million in 2025, then declined by 0.13% to -$29.6 million in 2026.
- The last three Profit After Tax figures came in at -$29.6 million (Q1 2026), -$29.6 million (Q4 2025), and -$28.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -29.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.60 Mn |
| Dec 31, 2025 | -29.56 Mn |
| Sep 30, 2025 | -28.71 Mn |
| Jun 30, 2025 | -30.57 Mn |
| Mar 31, 2025 | -26.35 Mn |
| Dec 31, 2024 | -28.98 Mn |
| Sep 30, 2024 | -27.40 Mn |
| Jun 30, 2024 | -24.75 Mn |
| Mar 31, 2024 | -21.98 Mn |
| Dec 31, 2023 | -23.55 Mn |
| Sep 30, 2023 | -21.99 Mn |
| Jun 30, 2023 | -41.67 Mn |
| Mar 31, 2023 | -23.36 Mn |
| Dec 31, 2022 | -19.47 Mn |
| Sep 30, 2022 | -27.26 Mn |
| Jun 30, 2022 | -28.68 Mn |
| Mar 31, 2022 | -29.49 Mn |
| Dec 31, 2021 | -25.17 Mn |
| Sep 30, 2021 | -23.63 Mn |
| Jun 30, 2021 | -41.20 Mn |